Home / Healthcare / Angiogenesis Modulators

Angiogenesis Modulators

Published: Jul 2013 | No Of Pages: 250 | Published By: RI Technologies

This report on Angiogenesis Modulators & Therapeutics studies the impact of Inhibitors and Stimulators on various diseases. The study focuses on major angiogenesis inhibitors and their role in diseases such as cancer, cardiology, ophthalmology, and other angiogenesis based diseases including endometriosis and inflammatory diseases. The emphasis is also given on major angiogenesis stimulators and their role in diseases such as cardiovascular disorders including ischemia, congestive heart failure, coronary artery disease, myocardial infarction and peripheral vascular disease and chronic wound care. The study provides global market analysis for angiogenesis therapeutic products by the above angiogenesis modulators and also by the disease areas such as cancer, cardiovascular disorders and other angiogenesis based diseases. Compilation of Worldwide Patents and Research related to Angiogenesis is also provided. The study includes estimations and predictions for the total global angiogenesis therapeutic products market. Estimations and predictions are also graphically illustrated by geographic regions encompassing the North America, Europe, Asia-Pacific and Rest of World.

1. SCOPE AND METHODOLOGY

2. REPORT SYNOPSIS
2.1 Introduction
Angiogenesis
Angiogenesis Modulators
Angiogenesis Therapeutic Products
Exhibit 1. Segmentation of Global Angiogenesis Modulators & Therapeutics Market by Angiogenesis Modulators and Therapeutic Area
Angiogenesis Modulators
Angiogenesis Inhibitors
Angiogenesis Stimulators
Angiogenesis – Therapeutic Areas
Cancer
Cardiovascular
Ophthalmology
Other
2.2 Angiogenesis Modulators & Therapeutics - Global Market Analysis
Exhibit 2. Angiogenesis Modulators & Therapeutics - Global Market Estimations & Predictions (2005 -2020) in US$ Million (Graphical Representation Included)
Exhibit 3. List of Major Global Companies in Angiogenesis Modulators & Therapeutic Products Market

3. MARKET DYNAMICS
3.1 Market Overview
3.2 Global Angiogenesis Modulators & Therapeutics Market
Exhibit 4. Angiogenesis Modulators & Therapeutics - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 5. Angiogenesis Modulators & Therapeutics – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.3 North American Angiogenesis Modulators & Therapeutics Market
Exhibit 6. Angiogenesis Modulators & Therapeutics – North American Market Estimations & Predictions (2005 - 2020) by Country for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 7. Angiogenesis Modulators & Therapeutics – North American Market Shares (2010, 2015 & 2020) by Country for United States and Canada (Graphical Representation Included)
3.3 (I) United States Angiogenesis Modulators & Therapeutics Market
3.3 (II) Canadian Angiogenesis Modulators & Therapeutics Market
Exhibit 8. List of Major North American Companies in Angiogenesis Modulators & Therapeutic Products Market
3.4 European Angiogenesis Modulators & Therapeutics Market
Exhibit 9. Angiogenesis Modulators & Therapeutics - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe in US$ Million
Exhibit 10. Angiogenesis Modulators & Therapeutics – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe
3.4 (I) German Angiogenesis Modulators & Therapeutics Market
3.4 (II) UK Angiogenesis Modulators & Therapeutics Market
3.4 (III) French Angiogenesis Modulators & Therapeutics Market
3.4 (IV) Swiss Angiogenesis Modulators & Therapeutics Market
3.4 (V) Russia Angiogenesis Modulators & Therapeutics Market
Exhibit 11. List of Major European Companies in Angiogenesis Modulators & Therapeutic Products Market
3.5 Asia-Pacific Angiogenesis Modulators & Therapeutics Market
Exhibit 12. Angiogenesis Modulators & Therapeutics - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  in US$ Million (Graphical Representation Included)
Exhibit 13. Angiogenesis Modulators & Therapeutics – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  (Graphical Representation Included)
3.5 (I) Japanese Angiogenesis Modulators & Therapeutics Market
3.5 (II) Chinese Angiogenesis Modulators & Therapeutics Market
3.5 (III) South Korean Angiogenesis Modulators & Therapeutics Market
3.5 (IV) Indian Angiogenesis Modulators & Therapeutics Market
Exhibit 14. List of Major Asia-Pacific Companies in Angiogenesis Modulators & Therapeutic Products Market
3.6 Rest of World Angiogenesis Modulators & Therapeutics Market
Exhibit 15. Angiogenesis Modulators & Therapeutics - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Australia, Brazil, South Africa, Israel and Other in US$ Million (Graphical Representation Included)
Exhibit 16. Angiogenesis Modulators & Therapeutics – Rest of World Market Shares (2010, 2015 & 2020) by Country for Australia, Brazil, South Africa, Israel and Other (Graphical Representation Included)
3.6 (I) Australian Angiogenesis Modulators & Therapeutics Market
3.6 (II) Brazilian Angiogenesis Modulators & Therapeutics Market
3.6 (III) South African Angiogenesis Modulators & Therapeutics Market
3.6 (IV) Israeli Angiogenesis Modulators & Therapeutics Market
Exhibit 17. List of Major Rest of World Companies in Angiogenesis Modulators & Therapeutic Products Market
3.7 Company Profiles - Major Players in Angiogenesis Market
Abbott Laboratories
Adnexus Therapeutics, Inc.
Alcon, Inc.
Amgen, Inc.
Ångstrom Pharmaceuticals, Inc.
Antisoma plc
More….
3.8 Major Activities in Angiogenesis Market
Cardium Therapeutics Develops Polymer Based Nitric Oxide Technology for Healing Wounds
Ethical Oncology Science Initiated Phase I Trial of E-3810
Tracon initiates TRC 105 Antibody Therapy for Prostate Cancer
VEGF Trap Eye to Treat Patients with Diabetic Macular Edema:
ENMD-2076 Demonstrates Preclinical Antitumor Activity in Colorectal Cancer
FDA Grants Orphan Drug Status to ENMD-2076 in Leukemia
PolyMedix Receives US Patent for Angiogenesis Inhibitor Compounds
FDA Grants Orphan Drug Status to VEGFb™ to Treat Advanced Melanoma
ThromboGenics and BioInvent in Strategic Alliance with Roche for TB-403, an Innovative Anti-Cancer Antibody
More….
3.9 Analysis by Modulators
Exhibit 18. Angiogenesis Modulators & Therapeutics – Global Market Estimations & Predictions (2005 - 2020) by Angiogenesis Modulators for Inhibitors and Stimulators in US$ Million (Graphical Representation Included)
Exhibit 19. Angiogenesis Modulators & Therapeutics – Global Market Shares (2010, 2015 & 2020) by Angiogenesis Modulators for Inhibitors and Stimulators (Graphical Representation Included)
3.9.1 Angiogenesis Inhibitors
3.9.1.1 Global Angiogenesis Inhibitors Market
Exhibit 20. Angiogenesis Inhibitors - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 21. Angiogenesis Inhibitors – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.9.1.2 North American Angiogenesis Inhibitors Market
Exhibit 22. Angiogenesis Inhibitors – North American Market Estimations & Predictions (2005 - 2020) by Country for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 23. Angiogenesis Inhibitors – North American Market Shares (2010, 2015 & 2020) by Country for United States
and Canada (Graphical Representation Included)
3.9.1.2 (I) United States Angiogenesis Inhibitors Market
3.9.1.2 (II) Canadian Angiogenesis Inhibitors Market
3.9.1.3 European Angiogenesis Inhibitors Market
Exhibit 24. Angiogenesis Inhibitors - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 25. Angiogenesis Inhibitors – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe (Graphical Representation Included)
3.9.1.3 (I) German Angiogenesis Inhibitors Market
3.9.1.3 (II) UK Angiogenesis Inhibitors Market
3.9.1.3 (III) French Angiogenesis Inhibitors Market
3.9.1.3 (IV) Swiss Angiogenesis Inhibitors Market
3.9.1.3 (V) Russia Angiogenesis Inhibitors Market
3.9.1.4 Asia-Pacific Angiogenesis Inhibitors Market
Exhibit 26. Angiogenesis Inhibitors - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  in US$ Million (Graphical Representation Included)
Exhibit 27. Angiogenesis Inhibitors – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  (Graphical Representation Included)
3.9.1.4 (I) Japanese Angiogenesis Inhibitors Market
3.9.1.4 (II) Chinese Angiogenesis Inhibitors Market
3.9.1.4 (III) South Korean Angiogenesis Inhibitors Market
3.9.1.4 (IV) India Angiogenesis Inhibitors Market
3.9.5 Rest of World Angiogenesis Inhibitors Market
Exhibit 28. Angiogenesis Inhibitors - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Australia, Brazil, South Africa, Israel and Other in US$ Million (Graphical Representation Included)
Exhibit 29. Angiogenesis Inhibitors – Rest of World Market Shares (2010, 2015 & 2020) by Country for Australia, Brazil, South Africa, Israel and Other (Graphical Representation Included)
3.9.1.5 (I) Australian Angiogenesis Inhibitors Market
3.9.1.5 (II) Brazilian Angiogenesis Inhibitors Market
3.9.1.5 (III) South African Angiogenesis Inhibitors Market
3.9.1.5 (IV) Israeli Angiogenesis Inhibitors Market
3.9.2 Angiogenesis Stimulators
3.9.2.1 Global Angiogenesis Stimulators Market
Exhibit 30. Angiogenesis Stimulators - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 31. Angiogenesis Stimulators – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.9.2.2 North American Angiogenesis Stimulators Market
Exhibit 32. Angiogenesis Stimulators – North American Market Estimations & Predictions (2005 - 2020) by Country for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 33. Angiogenesis Stimulators – North American Market Shares (2010, 2015 & 2020) by Country for United States and Canada (Graphical Representation Included)
3.9.2.2 (I) United States Angiogenesis Stimulators Market
3.9.2.2 (II) Canadian Angiogenesis Stimulators Market
Exhibit 34. List of Major North American Angiogenesis Stimulators Companies
3.9.2.3 European Angiogenesis Stimulators Market
Exhibit 35. Angiogenesis Stimulators - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 36. Angiogenesis Stimulators – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe
3.9.2.3 (I) German Angiogenesis Stimulators Market
3.9.2.3 (II) UK Angiogenesis Stimulators Market
3.9.2.3 (III) French Angiogenesis Stimulators Market
3.9.2.3 (IV) Swiss Angiogenesis Stimulators Market
3.9.2.3 (V) Russian Angiogenesis Stimulators Market
Exhibit 37. List of Major European Angiogenesis Stimulators Companies
3.9.2.4 Asia-Pacific Angiogenesis Stimulators Market
Exhibit 38. Angiogenesis Stimulators - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  in US$ Million (Graphical Representation Included)
Exhibit 39. Angiogenesis Stimulators – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  (Graphical Representation Included)
3.9.2.4 (I) Japanese Angiogenesis Stimulators Market
3.9.2.4 (II) Chinese Angiogenesis Stimulators Market
3.9.2.4 (III) South Korean Angiogenesis Stimulators Market
3.9.2.4 (IV Indian Angiogenesis Stimulators Market
Exhibit 40. List of Major Asia-Pacific Angiogenesis Stimulators Companies
3.9.2.5 Rest of World Angiogenesis Stimulators Market
Exhibit 41. Angiogenesis Stimulators - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Australia, Brazil, South Africa, Israel and Other in US$ Million (Graphical Representation Included)
Exhibit 42. Angiogenesis Stimulators – Rest of World Market Shares (2010, 2015 & 2020) by Country for Australia, Brazil, South Africa, Israel and Other (Graphical Representation Included)
3.9.2.4 (I) Australian Angiogenesis Stimulators Market
3.9.2.4 (II) Brazilian Angiogenesis Stimulators Market
3.9.2.4 (III) South African Angiogenesis Stimulators Market
3.9.2.4 (IV) Israeli Angiogenesis Stimulators Market
3.10 Analysis by Therapeutic Area
Exhibit 43. Angiogenesis Therapeutic Areas - Global Market Estimations & Predictions (2005 - 2020) for Cancer, Cardiovascular, Ophthalmology and Other in US$ Million (Graphical Representation Included)
Exhibit 44. Angiogenesis Therapeutic Areas – Global Market Shares (2010, 2015 & 2020) for Cancer, Cardiovascular, Ophthalmology and Other
3.10.1 Cancer Angiogenesis Modulators & Therapeutics
3.10.1.1 Global Cancer Angiogenesis Modulators & Therapeutics Market
Exhibit 45. Angiogenesis Modulators & Therapeutics for Cancer – Global Value Market Estimations & Predictions (2005 - 2020) by Cancer Therapeutics for Lung Cancer, Colorectal Cancer, Breast Cancer and Other in US$ Million
Exhibit 46. Angiogenesis Modulators & Therapeutics for Cancer – Global Value Market Shares (2010, 2015 & 2020) by Cancer Therapeutics for Lung Cancer, Colorectal Cancer, Breast Cancer and Other
Exhibit 47. Angiogenesis Modulators & Therapeutics for Cancer - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 48. Angiogenesis Modulators & Therapeutics for Cancer – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.10.1.1 (I) North American Cancer Angiogenesis Modulators & Therapeutics Market
3.10.1.1 (II) European Cancer Angiogenesis Modulators & Therapeutics Market
3.10.1.1 (III) Asia-Pacific Cancer Angiogenesis Modulators & Therapeutics Market
3.10.1.1 (IV) Rest of World Cancer Angiogenesis Modulators & Therapeutics Market
3.10.2 Cardiovascular Angiogenesis Modulators & Therapeutics
3.10.2.1 Global Cardiovascular Angiogenesis Modulators & Therapeutics Market
Exhibit 49. Angiogenesis Modulators & Therapeutics for Cardiovascular Diseases - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 50. Angiogenesis Modulators & Therapeutics for Cardiovascular Diseases – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.10.2.1 (I) North American Cardiovascular Angiogenesis Modulators & Therapeutics Market
3.10.2.1 (II) European Cardiovascular Angiogenesis Modulators & Therapeutics Market
3.10.2.1 (III) Asia-Pacific Cardiovascular Angiogenesis Modulators & Therapeutics Market
3.10.2.1 (IV) Rest of World Cardiovascular Angiogenesis Modulators & Therapeutics Market
3.10.3 Angiogenesis Modulators & Therapeutics for Other Diseases
3.10.3.1 Global Market for Angiogenesis Modulators & Therapeutics for Other Diseases
Exhibit 51. Angiogenesis Modulators & Therapeutics for Other Angiogenesis based Diseases - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 52. Angiogenesis Modulators & Therapeutics for Other Angiogenesis based Diseases – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.11 Angiogenesis Modulators & Therapeutics – Market Outlook

4. PRODUCT/TECHNOLOGY RESEARCH
4.1 Introduction
Angiogenesis – The Growth of New Blood Vessels
The Process
The Types
Sprouting Angiogenesis
Role of Angioprotien in Sprouting of Angiogenesis
Intussusceptive Angiogenesis
Role of Intussusceptive Angiogenesis in Embryonic Vascular Network Configuration
Therapeutic Angiogenesis
Role of Therapeutic Angiogenesis in Various Diseases
Delivery of Drugs in Cancer Therapy through Angiogenesis
Angiogenic Therapy for Heart?
4.2 Modulators of Angiogenesis
Angiogenesis Inhibitors
Natural Angiogenesis Inhibitors
Angiostatin – A Potent Angiogenesis Inhibitor of Tumor Growth
Heparin Hexasaccharide Fragment
Interleukin-12
Placental Ribonuclease Inhibitor
Retinoids
Thrombospondin-1 (TSP-1)
Role of TSP-1 as Autocrine Negative Regulator for Human Dendritic Cell Activation
Cartilage Derived Inhibitor
Angioarrestin
Endostatin
Platelet Factor-4
Metalloproteinase Inhibitors
Interferon Alpha/Beta/Gamma
Other
Angiogenesis Stimulators
Natural Angiogenic Stimulators
Vascular Endothelial Growth Factor
VEGF Splice Variants and Their Functions
Role of VEGF in Various Diseases
Effect of VEGF & bFGF on In-vivo and In-vitro Conditions
Fibroblast Growth Factors
Basic FGF
Expression of bFGF (FGF2) in Various Diseases
Alzheimer's
Precursor Neural Cells of Mice
Acidic FGF
Role of aFGF in ADPKD
Expression of aFGF in Alzheimer's
Granulocyte Colony-Stimulating Factor
Impact of G-CSF on Neutrophils
The Usage of G-CSF in Pharma Industry
Angiogenin
Angiopoietin-1
Platelet Derived Endothelial Cell Growth Factor.
Uterine Cervical Cancers and Role of PD-ECGF
Leptin
Leptin’s MoA
Midkine
Placental Growth Factor
Stimulation of Inflammation and Swelling – A Role of Placental Growth Factor
Hepatocyte Growth Factor (HGF)/Scatter Factor (SF)
Transforming Growth Factor (TGF)
TGFá
The TGFâ receptor
Other
4.3 Angiogenesis in Diseases
Remedy of Diseases with Angiogenesis Inhibitors
Angiogenesis Inhibitors-Patient Demographics
Exhibit 53. Angiogenesis Inhibitors - Global Market Estimations & Predictions (2005 -2020) of Patients Treated in Million
Cancer Therapy – Role of Angiogenesis
Global Market for Major Cancer Types
Exhibit 54. Global Market for Major Cancer Types (2005 & 2006) – Breast, Colorectal, Lung and Prostate in US$ Million (Graphical Representation Included)
Cancer Therapy Angiogenesis Vs Conventional
Conventional Cancer Treatments
Surgery
Radiation Therapy for Healing Cancer
Chemotherapy Treatment
Hormone Stimulation Therapy
Process of Immuno Therapy
Experimenting Phase
Targeted Therapy
Angiostatic Therapy
Angiostatic Agents
Angiolytic Photodynamic Therapy
Researches in Development of Cancer Therapy
Angiobalans
Global Cancer Demographics
Exhibit 55. Cancer Incidents (2006, 2011 & 2020): Estimates and Projections for Global Cancer Incidents in
Million/Year with Mortality Percentage (Graphical Representation Included)
Alzheimer’s
Dermatology
Cosmetic Dermatology
Angiogenesis in Dermatology
Angiogenesis Inhibitor
Angiogenesis Stimulating Drugs
Psoriasis
Role of Angiogenesis in Psoriasis
Rosacea
Ophthalmology
Age Related Macular Degeneration
Advanced stage of vision loss
Causes
Characteristics of the disorder
Detection process of the Disorder
Non-Neo-vascular (dry) AMD
Neo-vascular (wet) AMD
Other Turmoil Based on Angiogenesis.
Rubeosis Iridis
Neovascularization
Neovascularization in Association with Angiogenesis
Rheumatology
Rheumatoid Arthritis
Angiogenesis in Rheumatoid Arthritis – Pathogenic and Therapeutic Implications
Skin Related Ailments
Deficient Angiogenesis in Skin Diseases
Osteoarthritis (OA), Angiogenesis and Inflammation
Other
Inflammatory Diseases
Growth of New Blood Vessels in Inflammation
Cause of joint swelling due to inflammation
Endometriosis
Symptoms of the Disease
3.2 Remedy of Diseases with Angiogenesis Stimulators
Wound Care – Role of Angiogenesis
Soluble Factors Responsible for Wound Angiogenesis
Diabetic Foot Ulcers
Angiogenesis in Cardiovascular Disorders
Growth Trends – Global Market for Angiogenesis Modulators & Therapeutics for
Cardiovascular Disorders
Ischemia
Role of ASK 1 in Angiogenesis during Ischemia
Role of NGF in Neo-Vascularization during Ischemic Conditions
Congestive Heart Failure
Root of CHF
Detection of CHF
Treatment of CHF
Role of Angiogenesis in CHF
Coronary Artery Disease
Angina
Heart Attack
Heart Failures
Arrhythmias
Symptoms Identified for CAD
Role of Angiogenesis in CAD Treatment
Peripheral Vascular Disease
Angiogenic Therapy for the Treatment of PVD
Peripheral Artery Disease
Therapeutic Angiogenesis in PAD
Myocardial Infarction
Treatment of Myocardial Infarction Using Non-Invasive Imaging of Myocardial Angiogenesis
4.4 Angiogenesis Modulators & Therapeutics - Research Briefs

5. CORPORATE DIRECTORY

6. PATENTS INFORMATION

Exhibit 1. Segmentation of Global Angiogenesis Modulators & Therapeutics Market by Angiogenesis Modulators and Therapeutic Area
Exhibit 2. Angiogenesis Modulators & Therapeutics - Global Market Estimations & Predictions (2005 -2020) in US$ Million (Graphical Representation Included)
Exhibit 3. List of Major Global Companies in Angiogenesis Modulators & Therapeutic Products Market
Exhibit 4. Angiogenesis Modulators & Therapeutics - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 5. Angiogenesis Modulators & Therapeutics – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 6. Angiogenesis Modulators & Therapeutics – North American Market Estimations & Predictions (2005 - 2020) by Country for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 7. Angiogenesis Modulators & Therapeutics – North American Market Shares (2010, 2015 & 2020) by Country for United States and Canada (Graphical Representation Included)
Exhibit 8. List of Major North American Companies in Angiogenesis Modulators & Therapeutic Products Market
Exhibit 9. Angiogenesis Modulators & Therapeutics - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe in US$ Million
Exhibit 10. Angiogenesis Modulators & Therapeutics – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe
Exhibit 11. List of Major European Companies in Angiogenesis Modulators & Therapeutic Products Market
Exhibit 12. Angiogenesis Modulators & Therapeutics - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  in US$ Million (Graphical Representation Included)
Exhibit 13. Angiogenesis Modulators & Therapeutics – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  (Graphical Representation Included)
Exhibit 14. List of Major Asia-Pacific Companies in Angiogenesis Modulators & Therapeutic Products Market
Exhibit 15. Angiogenesis Modulators & Therapeutics - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Australia, Brazil, South Africa, Israel and Other in US$ Million (Graphical Representation Included)
Exhibit 16. Angiogenesis Modulators & Therapeutics – Rest of World Market Shares (2010, 2015 & 2020) by Country for Australia, Brazil, South Africa, Israel and Other (Graphical Representation Included)
Exhibit 17. List of Major Rest of World Companies in Angiogenesis Modulators & Therapeutic Products Market
Exhibit 18. Angiogenesis Modulators & Therapeutics – Global Market Estimations & Predictions (2005 - 2020) by Angiogenesis Modulators for Inhibitors and Stimulators in US$ Million (Graphical Representation Included)
Exhibit 19. Angiogenesis Modulators & Therapeutics – Global Market Shares (2010, 2015 & 2020) by Angiogenesis Modulators for Inhibitors and Stimulators (Graphical Representation Included)
Exhibit 20. Angiogenesis Inhibitors - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 21. Angiogenesis Inhibitors – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 22. Angiogenesis Inhibitors – North American Market Estimations & Predictions (2005 - 2020) by Country for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 23. Angiogenesis Inhibitors – North American Market Shares (2010, 2015 & 2020) by Country for United States
Exhibit 24. Angiogenesis Inhibitors - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 25. Angiogenesis Inhibitors – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe (Graphical Representation Included)
Exhibit 26. Angiogenesis Inhibitors - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  in US$ Million (Graphical Representation Included)
Exhibit 27. Angiogenesis Inhibitors – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  (Graphical Representation Included)
Exhibit 28. Angiogenesis Inhibitors - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Australia, Brazil, South Africa, Israel and Other in US$ Million (Graphical Representation Included)
Exhibit 29. Angiogenesis Inhibitors – Rest of World Market Shares (2010, 2015 & 2020) by Country for Australia, Brazil, South Africa, Israel and Other (Graphical Representation Included)
Exhibit 30. Angiogenesis Stimulators - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 31. Angiogenesis Stimulators – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
Exhibit 32. Angiogenesis Stimulators – North American Market Estimations & Predictions (2005 - 2020) by Country for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 33. Angiogenesis Stimulators – North American Market Shares (2010, 2015 & 2020) by Country for United States and Canada (Graphical Representation Included)
Exhibit 34. List of Major North American Angiogenesis Stimulators Companies
Exhibit 35. Angiogenesis Stimulators - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 36. Angiogenesis Stimulators – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe
Exhibit 37. List of Major European Angiogenesis Stimulators Companies
Exhibit 38. Angiogenesis Stimulators - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  in US$ Million (Graphical Representation Included)
Exhibit 39. Angiogenesis Stimulators – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, South Korea, India and Rest of Asia-Pacific  (Graphical Representation Included)
Exhibit 40. List of Major Asia-Pacific Angiogenesis Stimulators Companies
Exhibit 41. Angiogenesis Stimulators - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Australia, Brazil, South Africa, Israel and Other in US$ Million (Graphical Representation Included)
Exhibit 42. Angiogenesis Stimulators – Rest of World Market Shares (2010, 2015 & 2020) by Country for Australia, Brazil, South Africa, Israel and Other (Graphical Representation Included)
Exhibit 43. Angiogenesis Therapeutic Areas - Global Market Estimations & Predictions (2005 - 2020) for Cancer, Cardiovascular, Ophthalmology and Other in US$ Million (Graphical Representation Included)
Exhibit 44. Angiogenesis Therapeutic Areas – Global Market Shares (2010, 2015 & 2020) for Cancer, Cardiovascular, Ophthalmology and Other
Exhibit 45. Angiogenesis Modulators & Therapeutics for Cancer – Global Value Market Estimations & Predictions (2005 - 2020) by Cancer Therapeutics for Lung Cancer, Colorectal Cancer, Breast Cancer and Other in US$ Million
Exhibit 46. Angiogenesis Modulators & Therapeutics for Cancer – Global Value Market Shares (2010, 2015 & 2020) by Cancer Therapeutics for Lung Cancer, Colorectal Cancer, Breast Cancer and Other
Exhibit 47. Angiogenesis Modulators & Therapeutics for Cancer - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 48. Angiogenesis Modulators & Therapeutics for Cancer – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
Exhibit 49. Angiogenesis Modulators & Therapeutics for Cardiovascular Diseases - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 50. Angiogenesis Modulators & Therapeutics for Cardiovascular Diseases – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
Exhibit 51. Angiogenesis Modulators & Therapeutics for Other Angiogenesis based Diseases - Global Market Estimations & Predictions (2005 -2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 52. Angiogenesis Modulators & Therapeutics for Other Angiogenesis based Diseases – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
Exhibit 53. Angiogenesis Inhibitors - Global Market Estimations & Predictions (2005 -2020) of Patients Treated in Million
Exhibit 54. Global Market for Major Cancer Types (2005 & 2006) – Breast, Colorectal, Lung and Prostate in US$ Million (Graphical Representation Included)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +